Key facts
- This page summarizes CCP III Cayman GP Ltd.'s Form 4 filing for GoHealth, Inc. (GOCOQ).
- 2 reported transactions and 10 derivative rows are listed below.
- Accepted by SEC: 17 Aug 2026, 21:45.
CCP III Cayman GP Ltd. - 21 Jul 2026 Form 4 Insider Report for GoHealth, Inc. (GOCOQ)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- GOCOQ
- Reported as of
- 21 Jul 2026
- Net transaction value
- $0
- SEC form
- 4
- Accepted by SEC
- 17 Aug 2026, 21:45:18 UTC
- Prior SEC filing
- 14 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- CCP III CAYMAN GP LTD. By: /s/ Susanne V. Clark, Authorized Signatory
Source evidence
Original filing metadata and source links for verification.
4 source fields
Reporting owner
1 detail
Key filing fact
CCP III Cayman GP Ltd. filed Form 4 for GoHealth, Inc. (GOCOQ) on 17 Aug 2026.
Change
- Previous filing in this sequence was filed on 14 Dec 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (10)
CIK 0001667801
Primary reporting owner
CCP III Cayman GP Ltd.
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- CCP III CAYMAN GP LTD. By: /s/ Susanne V. Clark, Authorized Signatory
- Signature date
- 17 Aug 2026
CIK 0001818016
Centerbridge Associates III, L.P.
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- CENTERBRIDGE ASSOCIATES III, L.P., By: CCP III CAYMAN GP LTD., its general partner, By: /s/ Susanne V. Clark, Authorized Signatory
- Signature date
- 17 Aug 2026
CIK 0001818077
CCP III AIV VII Holdings, L.P.
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- CCP III AIV VII HOLDINGS, L.P., By: CENTERBRIDGE ASSOCIATES III, L.P., its general partner, By: CCP III CAYMAN GP LTD., its general partner, By: /s/ Susanne V. Clark, Authorized Signatory
- Signature date
- 17 Aug 2026
CIK 0001785522
CB Blizzard Co-Invest Holdings, L.P.
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- CB BLIZZARD CO-INVEST HOLDINGS, L.P., By: CENTERBRIDGE ASSOCIATES III, L.P., its general partner, By: CCP III CAYMAN GP LTD., its general partner, By: /s/ Susanne V. Clark, Authorized Signatory
- Signature date
- 17 Aug 2026
CIK 0001818020
Blizzard Aggregator, LLC
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- BLIZZARD AGGREGATOR, LLC, By: CCP III CAYMAN GP LTD., its sole manager, By: /s/ Susanne V. Clark, Authorized Signatory
- Signature date
- 17 Aug 2026
CIK 0001425800
Aronson Jeffrey
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- JEFFREY H. ARONSON By: /s/ Jeffrey H. Aronson
- Signature date
- 17 Aug 2026
CIK 0001852144
CB Blizzard Lower Holdings GP A, LLC
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- CB BLIZZARD LOWER HOLDINGS GP A, LLC By: /s/ Susanne V. Clark, Authorized Signatory
- Signature date
- 17 Aug 2026
CIK 0001852252
CB Blizzard Lower Holdings A, L.P.
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- CB BLIZZARD LOWER HOLDINGS A, L.P., By: CB BLIZZARD LOWER HOLDINGS GP A, LLC, its general partner, By: /s/ Susanne V. Clark, Authorized Signatory
- Signature date
- 17 Aug 2026
CIK 0001852159
CB Blizzard Lower Holdings GP B, LLC
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- CB BLIZZARD LOWER HOLDINGS GP B, LLC By: /s/ Susanne V. Clark, Authorized Signatory
- Signature date
- 17 Aug 2026
CIK 0001852127
CB Blizzard Lower Holdings B, L.P.
- Relationship
- 10%+ Owner
- Address
- 375 PARK AVENUE, 13TH FLOOR, NEW YORK
- Signature
- CB BLIZZARD LOWER HOLDINGS B, L.P., By: CB BLIZZARD LOWER HOLDINGS GP B, LLC, its general partner, By: /s/ Susanne V. Clark, Authorized Signatory
- Signature date
- 17 Aug 2026
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
GOCOQ
transaction
Class A Common Stock
Disposed to Issuer
- Transaction value
- Shares
- -4,179,850
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Footnotes
- F1, F2, F3, F4, F5
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
GOCOQ
transaction
Derivative
LLC Interests of GoHealth Holdings, LLC
Disposed to Issuer
- Transaction value
- Shares
- -5,386,178
- Change %
- -100%
- Price
- Shares after
- 0
- Date
- 21 Jul 2026
- Ownership
- See footnotes
- Underlying class
- Class A Common Stock
- Underlying amount
- 5,386,178
- Exercise price
- Footnotes
- F2, F3, F4, F5, F6
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Section 16 status
CCP III Cayman GP Ltd. is no longer subject to Section 16 filing requirements. Form 4 or Form 5 obligations may still apply in specific circumstances.
Explanation of responses 6 footnotes
Footnote F1
On June 7, 2026, GoHealth, Inc. (the "Issuer"), GoHealth Holdings, LLC and certain of their direct and indirect subsidiaries filed voluntary petitions commencing cases under chapter 11 of title 11 of the United States Code in the United States Bankruptcy Court for the District of Delaware to implement a prepackaged Chapter 11 plan of reorganization (the "Plan"). The Plan became effective on July 21, 2026 (the "Effective Date"). Pursuant to the Plan, on the Effective Date, all of the Issuer's Class A common stock together with any shares of restricted stock, restricted stock units, or any other right to receive equity in the Issuer, in each case, outstanding immediately prior to the Effective Date, were cancelled, discharged and are of no force and effect.
Footnote F2
Pursuant to the Plan, the holders of Class A common stock and other Allowed GoHealth Holding Interests (as defined in the Plan), including the reporting person, are entitled to receive their pro rata share of an approximately $10.3 million cash equity recovery pool.
Footnote F3
Includes (i) 2,712,197 shares of Class A Common Stock previously held of record by CB Blizzard Lower Holdings A, L.P. ("CB Blizzard A") and (ii) 1,467,653 shares of Class A Common Stock previously held of record by CB Blizzard Holdings C, L.P. ("CB Blizzard C").
Footnote F4
CCP III Cayman GP Ltd. ("CCP GP") is the general partner of CB Blizzard C and may be deemed to share beneficial ownership of the securities held of record by CB Blizzard C. CCP GP is also the general partner of Centerbridge Associates III, L.P., which is the general partner of each of CCP III AIV VII Holdings, L.P. and CB Blizzard Co-Invest Holdings, L.P., which are the owners of CB Blizzard Lower Holdings GP A, LLC, which is the general partner of CB Blizzard A. As a result, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by CB Blizzard A. CCP GP is also the sole manager of Blizzard Aggregator, LLC, which is the owner of CB Blizzard Lower Holdings GP B, LLC, which is the general partner of CB Blizzard Lower Holdings B, L.P. ("CB Blizzard B"). As a result, each of the foregoing entities may be deemed to share beneficial ownership of the securities held of record by CB Blizzard B.
Footnote F5
Jeffrey H. Aronson is the sole director of CCP GP and, as a result, may be deemed to share beneficial ownership of the securities held of record by each of CB Blizzard A, CB Blizzard C and CB Blizzard B. However, none of the foregoing should be construed in and of itself as an admission by Mr. Aronson or by any Reporting Person as to beneficial ownership of securities owned by another Reporting Person. In addition, Mr. Aronson expressly disclaims beneficial ownership of the securities held of record by each of CB Blizzard A, CB Blizzard C and CB Blizzard B, except to the extent of any proportionate pecuniary interest therein.
Footnote F6
The LLC Interests of GoHealth Holdings, LLC were redeemable for an equal number of shares of Class A common stock.
SEC remarks
Due to the limitations of the electronic filing system, CB Blizzard Holdings C, L.P. is filing on a separate Form 4.